Written Question·Department of Health and Social Care·UIN 50756

Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction

Tabled: 7 May 2025

Answered: 13 May 2025

Named Day

Question

Jayne Kirkham

To ask the Secretary of State for Health and Social Care, if he will recognise Post-SSRI Sexual Dysfunction as a condition.

Answer

Karin Smyth

The current Medicines and Healthcare products Regulatory Agency (MHRA) approved product information for selective serotonin reuptake inhibitors (SSRIs) has a warning for the risk of sexual dysfunction where symptoms continue despite stopping treatment. Th...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 50756) →